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ABSTRACT
Non-homologous end joining (NHEJ) and homolog-
ous recombination (HR) are pathways that repair
DNA double-strand breaks (DSBs). In Saccharomyces
cerevisiae, the repair of these breaks is influenced by
histone acetylation. Therefore, we tested mammalian
cells deleted for NHEJ (Ku80 or DNA Ligase IV)o r
altered for HR (breast cancer associated gene,
Brca2, or Bloom’s syndrome, Blm) for sensitivity to
trichostatin A (TSA), a histone deacetylase inhibitor
thatisbeinginvestigatedasananti-cancertherapeutic.
We show that cells mutated for Ku80 (ku80
 / )o rDNA
Ligase IV (lig 4
 / ), but not cells mutated for Brca2
(brca2
lex1/lex2)o rBlm (blm
tm3Brd/tm4Brd),are hypersens-
itivetoTSAinadose-dependentmanner.TSA-induced
toxicitystimulatesapoptosisandcellcyclecheckpoint
responses independent of p53, but does not increase
phosphorylated histone H2AX (g-H2AX) as compared
with a clastogenic agent, camptothecin, indicating
that the quantity of DSBs is not the primary cause of
TSA-induced cell death. In addition, we show that
potential anti-cancer drugs (LY-294002 and vanillin)
thatinhibitthefamilyofphosphatidylinositol3kinases
that include the NHEJ protein, DNA–PKCS act in syn-
ergy with TSA to reduce the viability of HeLa cells in
tissue culture presenting the possibility of using the
two drugs in combination to treat cancer.
INTRODUCTION
In mammals, non-homologous end joining (NHEJ) and homo-
logous recombination (HR) are the two major pathways that
repair double-strand breaks (DSBs) in DNA. Both are con-
servedfromyeasttomammals.NHEJrepairsDSBsthroughan
imprecise pathway that joins ends together (1). There are six
proteins known to be important for NHEJ in mammals: Ku80,
Ku70, DNA–PKCS, Artemis, Xrcc4 and Lig 4. Ku80 forms a
heterodimer with Ku70, called Ku, and along with the phos-
phatidylinositol 3 (PI-3) kinase catalytic subunit, DNA–PKCS,
forms a holoenzyme referred to as DNA dependent–protein
kinase(DNA–PK).Artemisforms acomplexwith DNA–PKCS
that opens hairpins and processes overhangs. Xrcc4 forms a
heterodimer with Lig 4 to stimulate ligation of DNA DSBs.
By contrast HR repairs DNA DSBs through a precise pathway
that utilizes acomplementary templateusually provided by the
sister chromatid during DNA replication (2). There are many
proteins important for HR including Rad51 that forms a ﬁla-
ment on the single-strand ends at the DSB to promote strand
exchange. Also important for HR is the breast cancer associ-
ated gene, Brca2, that associates with Rad51 in two regions,
the BRC motifs encoded by exon 11 (3) and a unique region
encoded in exon 27 (4). There are also proteins that inﬂuence
HR that includes Blm, a member of the RecQ family of hel-
icases (5). Both NHEJ and HR are critical for maintaining
genomic stability.
The consequences of impairing either NHEJ or HR have
been investigated in mice and similar phenotypes are caused
by defects in either pathway: hypersensitivity to ionizing
radiation (4,6), genomic instability (6–11) and replicative
senescence of mouse embryonic ﬁbroblasts (MEFs)
(6,9,10,12,13). In addition, Blm mutations increase sister
chromatid exchanges that leads to increased HR and chromo-
somal instability (14,15) demonstrating that Blm suppresses
recombination and that unregulated recombination can be
mutagenic. Thus, both NHEJ and HR are important
for genomic stability and neither can fully compensate for
deletion of the other.
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ku80
 /  (16,17) and lig 4
 /  (18) mice survive to adulthood;
albeit Ku80 istoxic inthe absence ofLig4andmustbedeleted
for lig4
 /  mice to survive (19,20). In contrast, rad51
 /  (6)
and brca2
 /  (4) cells cannot survive and as a result these
mutant embryos arrest soon after implantation. However,
COOH-terminal truncations of Brca2 that remove some but
not all of the regions that associate with Rad51 cause less
severe phenotypes (21–24). These mice can live but develop
cancer earlier than controls. Deletion of Blm is also lethal but
mice survive with a mutation that permits the generation of
low protein levels. These mice develop cancer due to loss of
heterozygosity caused by HR (14,15).
The tumor suppressor protein, p53, mediates responses
to damaged DNA and strongly contributes to severity of the
phenotypes for NHEJ- and HR-mutated mice; these pheno-
types are ameliorated by deletion of p53. For rad51
 /  and
brca2
 /  mice, p53 deletion allows the embryos to live longer
and undergo more cellular proliferation and differentiation
before they die (6,25). For lig 4
 /  mice, p53 deletion
rescues late embryonic lethality caused by neuronal apoptosis.
In addition, p53 deletion rescues replicative senescence of
MEF derived from either ku80
 /  or lig 4
 /  embryos.
Even though replicative senescence is rescued, these NHEJ-
null cells are still extremely sensitive to ionizing radiation
demonstrating that failure to repair DNA DSBs by NHEJ
does not hinder cellular proliferation, instead proliferation
is inhibited by the p53-response to these inefﬁciently repaired
breaks. Thus, p53-mediated responses increase the severity
of these phenotypes caused by deletion of either NHEJ
or HR.
In addition to p53-mediated responses, the repair of DNA
DSBs is inﬂuenced by chromatin as shown in the budding
yeast, Saccharomyces cerevisiae. Chromatin is the complex
of DNA and proteins composed of core histones H2A, H2B,
H3 and H4. These core histones package DNA into nucle-
osomes and can be acetylated on the e-amino groups of lysines
found in the N-terminal tails. Histone acetylation opens
chromatin and is performed by enzymes called histone acet-
yltransferases (HATs) while histone deacetylation compacts
chromatin and is performed by enzymes called histone
deacetylases (HDACs) (26). These functions inﬂuence cellular
responses to environmental stresses in a tightly regulated
manner (27).
The status of histone acetylation inﬂuences the repair of
DNA DSBs in S.cerevisiae and possibly mammals. Mutations
of tail lysines that prevent acetylation in histone H4 sensitizes
yeast cells to DNA damaging agents that cause breaks but not
intrastrand photoproducts (28). Esa1p, a HAT, is required for
normal NHEJ (28) and haploid cells impaired for nucleosomal
histone H4 acetylation, owing to deletion of Yng2, are sens-
itive to DNA damage in S phase and non-viable after deletion
of NHEJ, but not HR (29). Thus, histone acetylation appears to
beimportantforthe repair ofDSBs. Bycontrast,subunits ofan
HDAC (Sin3p and Rpd3p) that catalyzes histone deacetylation
near a DNA DSB facilitate the repair of a HO-induced DSB
by NHEJ but not by HR (30). For mammalian cells, histone
acetylation may also be important for the repair of DNA DSBs
since TIP60, the mammalian homolog to ESA1, appears to be
important for DSB repair (31) and another HAT, GCN5, inter-
acts with Ku70 (32). Thus, the status of histone acetylation
adjacent to DSBs appears to be important for efﬁcient NHEJ in
yeast and mammalian cells.
Here we investigate the effect trichostatin A (TSA) (33,34)
exposure has on cells mutated for the NHEJ genes, Ku80 and
Lig 4, the HR gene, Brca2 and the HR-inﬂuencing gene Blm.
TSA is a hydroxamic acid-based HDAC inhibitor that alters
the expression of  2% of expressed genes including upregu-
lation of p21
Cip1 and causes growth arrest, differentiation or
apoptosis of a variety of transformed cells. Hydroxamic acid-
based compounds are considered promising anti-cancer agents
and have been reported to have anti-tumor effects in animals
(35).CellsablatedforNHEJbydeletionofeitherKu80orLig4
are hypersensitive to TSA; however, cells impaired for HR by
deletion of Brca2 exon 27 or derepressed for HR by mutation
of Blm exhibit the same level of resistance to TSA as control
cells. Exposure to TSA reduced cell number for NHEJ-
defective cells by both apoptosis and checkpoint responses
that were independent of p53 function. TSA does not appear
to generate DSBs as judged by levels of g-H2AX. The PI-3
kinases inhibitors, LY-29400 and vanillin, that may inhibit
DNA–PKcs act in synergy with TSA to reduce numbers
of HeLa cells, offering the potential for a novel anti-cancer
regiment.
MATERIALS AND METHODS
TSA dose response and time course for primary MEF
TSA dose response for primary MEFs. Primary MEF
(5.4 · 10
4), at passage 3, was plated onto 35 mm wells on
day 0. Cells were grown in M15 [15% fetal bovine serum
(FBS) from HyClone, DMEM from Life Technologies, Inc.,
10
 4 M b-mercaptoethanol, 2 mM L-glutamine, 49.5 U/ml
penicillin and 38.8 mg/ml streptomycin] supplemented with
TSA at a variety of concentrations (0, 2.5, 12, 60 and 300 nM).
The media was changed every 3.5 days and maintained in the
same TSA concentration. MEF were trypsinized and viable
cells counted in the presence of trypan blue on day 10. Two
clones from each genotype were tested.
TSA time course for primary MEF. Passage 3 MEF was
plated in replica on day zero (5.4 · 10
4/35 mm wells). One
replicasetofcellswas exposedtono TSAandthe otherreplica
set to 33 nM TSA. Media was changed every three days with
the same TSA concentration. Viable cells were counted in the
presence of trypan blue. Two clones were tested for each
genotype.
Dose response, time course and Annexin V analysis
for immortalized MEF
TSA and camptothecin (CPT) dose response for immortalized
MEF. These dose response experiments were performed as
described previously for HeLa cells (36).
TSA time course for immortalized MEF. This time course
experiment was performed as described previously for HeLa
cells (36)except10000cellswere seededontothe 35mMwell
of 6-well plates instead of 1000 cells in the 15 mM well of a
24-well plate.
Annexin V staining cells were measured along with the time
course as described previously for HeLa cells (36).
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(EGFP)–HsKu80 and stable cell lines expressing
the fusion protein
Full-length cDNA encoding the 80 kD subunit of human Ku
protein (HsKu80) was excised from the original pBluescript
construct (37) with EcoRI and inserted into EcoRI site of the
pEGFP-N2 expression vector (Clontech). In addition, a
cassette that codes for blasticidin (38) was inserted into the
SacI–AccI sites of the same construct.
A clone of p53
 / ku80
 /  MEF at a passage >50, was
transfected with EGFP–HsKu80 or EGFP by electroporation:
1 · 10
7 MEF cells in 1 ml of Ca-free phosphate-buffered
saline (PBS) were electroporated with 10 mg plasmid at
25 V and 900 mkF. To select for stable trasfectants, cells
were grown in a medium containing 5 mg/ml blasticidin.
Cells grew for >2 weeks. Blasticidin resistant colonies were
picked, expanded and tested for Ku function.
Response of EGFP–HsKu80 and EGFP cells to
g-radiation or to a pulse of high concentration TSA
Exponentially growing blasticidin-resistant MEF were
trypsinized and counted. Then 1 · 10
4 cells in 1 ml PBS were
exposed to g-radiation (Gammator B irradiator with
137Cs,
290 RAD/min) at doses of 0, 100, 200, 400 and 1000 Rad
and seeded at a variety of concentrations (500, 1000 and
5000 cells/10 mm plate). After incubation for two weeks,
cells were stained with crystal violet and colonies of 16 or
morecellswere counted. The survival fraction was determined
(100% · the number of TSA exposed colonies/the number of
unexposed colonies).
Survival fraction of MEF exposed to 100 nM TSA. MEFs
were seeded at low density (250–500 cells/35 mm plate) and
exposed to 100 nM TSA for 0, 24 and 48 h (washed with PBS
and re-fed with fresh M15 without TSA). After incubation for
2 weeks, colonies were stained with crystal violet and colonies
of 16 or more cells were counted. The survival fraction was
determined (100% · the number of TSA exposed colonies/the
number of unexposed colonies).
Growth curve of MEFs exposed to a pulse of 500 nM TSA.
MEF were seeded (1 · 10
5 cells/35 mm plate) in either no
TSA or 500 nM TSA for 24 h on day 0. The plates were then
washed with PBS and re-fed with fresh M10 without TSA.
Cells were fed fresh M10, without TSA, every 2 days. MEFs
were trypsinized and viable cells counted in the presence of
trypan blue.
Observation of green fluorescence in EGFP–HsKu80
and EGFP MEF
Stably transfected cells were grown on cover slips and treated
with either no TSA or 100 nM TSA for 2–24 h. Cells were
ﬁxed for 20 min at room temperature with 4% paraformalde-
hyde in PBS, washed three times with PBS and observed under
epiﬂuorescent illumination.
Immunoblotting
Immunoblotting was used to determine expression levels of
the EGFP fusion proteins as well as to monitor the up- or
down-regulation of various markers for cellular proliferation.
For preparation of whole cell lysates TSA treated or non-
treated cells were washed with PBS and suspended in
50 mM Tris–HCl, pH7.5, containing 0.5 M NaCl, 1 mM
DTT, 1 mM MgCl2, 0.1 mM EDTA, 20% glycerol and a
complete cocktail of protease inhibitors from Boehringer.
After extensive homogenization and freeze/thawing on dry
ice, the extracts were clariﬁed by centrifugation for 10 min
at 12000· g and applied to SDS–PAGE. The Western blotting
was carried out as described previously (39) using the BCL kit
from Amersham. HsKu80 was detected using previously
described monoclonal antibodies (40,41). Anti-EGFP
antibody was purchased from Clontech, anti-p21
Cip1, anti-
p16
INK4a and anti-pRb from Santa Cruz and anti-acetyl-
lysine antibodies from Upstate Biotechnology. A portion of
the same gel was stained with Coomassie to conﬁrm the equal
loading for each lane.
Detection of g-H2AX
The level of g-H2AX was detected by three different methods.
(i) Flowcytometry.Cells(2 · 10
5)wereseededontoa35mM
plate,24hbeforeanalysis.Cellsweretreatedwithdifferent
dosagesofTSAandCPTfor2hthencellsweretypsinized.
Levels of phosphorylated H2AX were detected following
the protocol provided by the assay kit (Upstate).
(ii) Immunocytochemistry. Cells (5 · 10
4) were seeded in
chamber slides. After 24 h these cells were treated with
different dosages of TSA and CPT for 2 h and then fixed
with 95% ethanol and 5% acetic acid for 5 min and
then blocked with 3% BSA/TBS for 1 h. For 1 h, cells
were exposed to 2 mg/ml of anti-phospho-Histone
H2A.X(Ser139) (UpstateBiotechnology)inblocking buf-
fer and then washed with TBS for 5 min. The secondary
antibody was added in blocking buffer [1:200 of Alexa
Fluro 488goatanti-mouseIgG(H+L)](MolecularProbes)
and cells were observed under a fluorescent microscope.
(iii) Western. The same conditions were used as for flow
cytometry to seed and treat cells. Whole cell extract
was generated using protein sample buffer followed
by a standard western blotting procedure with anti-
phospho-Histone H2A.X (Ser139) (Upstate).
Dose response to DNA–PK inhibitors
Three DNA–PK inhibitors, LY-294002, vanillin (Sigma)
and NU-7026 (Calbiochem), were tested. LY-294002 was
dissolved in DMSO to make a stock concentration 25 mM.
Vanillin was dissolved in H2O by heating to 70 C to make a
stock concentration 100 mM. NU-7026 was dissolved in
DMSO to make a stock concentration 10 mM. Dose response
experiments were performed as described previously for
HeLa cells (36).
RESULTS
Ku80 and Lig 4, but not Brca2 exon 27 or Blm,
are important for cellular survival after
exposure to TSA
We compared primary cultures of Ku80
+/ , ku80
 / , p53
 / 
and p53
 /  ku80
 /  MEFs (passage 3) for their response to
TSA. These cells were continuously exposed for 10 days to
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300 nM. MEFs for all genotypes showed greatly reduced cell
number while exposed to a continuous concentration of
60–300 nM TSA (Figure 1A). After 10 days exposure to
300 nM TSA, proliferation was completely and permanently
halted for MEF of all genotypes, even after removal of TSA
(data not shown). For all genotypes the MEF that remained
in the well presented with a senescent morphology. Thus,
cellular senescence is not dependent on p53 after exposure
to this high concentration of TSA for 10 days as predicted by
previous results (42,43).
It is important to avoid high concentrations of TSA that may
override any compensatory differences between these genet-
ically altered clones of cells; therefore, a continuous low dose
of 33 nM was chosen to investigate the impact that TSA has on
early passage MEF. A time course was used to compare the
Figure 1. Sensitivity of DNA DSB repair altered cells to TSA. (A and B) Primary clones of MEFs exposed to TSA. (A) Dose response to a continuous exposure to
TSA(0,2.5,12,60and300nM).Theaverageoftwoclonesforeachgenotypeisshown.Ku80
+/ ,square;p53
 / NHEJ+,circle;ku80
 / ,triangle;p53
 / ku80
 / ,
crosses.(B)Timecoursesto 33nMTSAasshownbya growthcurve.MEFnotexposedtoTSA(closedsymbols),MEFscontinuouslyexposedto33nMTSA(open
symbols). The average of two clones from each genotype is shown. (C and D) TSA exposure of 3T3 immortalized clones of MEF. (C) Dose response to TSA.
Immortalizationofku80
 / andlig4
 / MEFsrequiredeletionofp53.Thus,theku80
 / andlig4
 / MEFsandtheircontrols(p53
 / NHEJ+)arealsomutatedfor
p53.Theseclonesareina129·C57blbackground.Immortalizationofbrca2
lex1/lex2MEFdoesnotrequiredeletionofp53(althoughp53functionmaybelostduring
the immortalization process).The brca2
lex1/lex2 MEF and itscontrol are in a 129SvEvbackground.Symbolsare the same as for(A), in additionp53
 /  lig 4
 / , 1;
brca2
+/+,opendiamond;brca2
lex1/lex2,closeddiamond.(D)Timecourseto33nMTSA.(E)Timecourseto100nMTSA.(F)Doseresponseofbrca2
lex1/lex2(closed
diamond), blm
tm3Brd/tm4Brd (closed upside down triangle) and wild-type (open diamond) ES cells (129SvEv) to TSA.
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for populations of Ku80
+/ , ku80
 / , p53
 /  and p53
 / 
ku80
 /  MEFs at passage 3 (Figure 1B). Except for p53
 / 
MEFs, exposure to 33 nM TSA greatly reduced cell number
throughout the entire 9 days of the study. However, exposure
to 33 nM TSA only moderately reduced the number of p53
 / 
MEFs and this reduction diminished during the course of the
analysis from  60 to 30% at 4 and 9 days, respectively. These
results indicate that TSA reduces cell number at least partly
through p53 that can only be observed at a low TSA concen-
tration. Furthermore, these results show that Ku80 is important
for recovery of the p53
 /  MEF, since p53
 /  ku80
 /  MEF
wereunabletorecoverwhileexposedto33 nMTSA.Thus,the
presence of Ku80 and the absence of p53 are important for
resistance of primary MEF exposed to 33 nM TSA.
Immortalized MEFs (approximately passage 45) deleted
for either Ku80 (12), Lig 4 (18,44) or Brca2 exon 27
(brca2
lex1/lex2) (23) were compared, to determine if either
NHEJ or HR are important for recovery of cells exposed to
TSA. The ku80
 /  and the lig 4
 /  MEF and their controls are
mutatedforp53toenable proliferation(thus,their control cells
are p53
 /  NHEJ+) while the brca2
lex1/lex2 MEF and its con-
trol were not mutated for p53 (albeit p53 function may have
been lost during the 3T3 immortalization process). For Brca2,
a partial loss of function mutation is analyzed since complete
deletion kills the cell; thus, one must interpret data generated
from these cells with the understanding that HR is only
diminished, not ablated. The brca2
lex1/lex2 MEF generates a
truncated protein that still interacts with Rad51 in the nucleus
(45). These MEF, brca2
lex1/lex2, have diminished HR function
that causes genomic instability, reduced homology-directed
repair and hypersensitivity to agents that cause DSBs
(23,24,45). A dose response curve shows that both p53
 / 
ku80
 /  and p53
 /  lig 4
 /  MEFs, but not brca2
lex1/lex2
MEF, are hypersensitive to TSA compared with their control
MEF (Figure 1C). A time course conﬁrms the dose response
curvesincebothp53
 / ku80
 / andp53
 / lig4
 / MEFsare
hypersensitive to 33 nM TSA, compared with p53
 /  NHEJ+
MEFs (Figure 1D). However, at 100 nM TSA, the ku80
 / 
MEFs appear to be more sensitive than the lig 4
 /  MEF.
A time course performed at 100 nM TSA conﬁrms this
observation (Figure 1E). Thus, the NHEJ proteins, Ku80
and Lig 4, but not the HR protein Brca2, are important for
resistance to TSA. In addition, relative importance of Ku80
and Lig 4 appears to depend on TSA dose with both proteins
exhibiting equal importance at 33 nM while Ku80 exhibits
greater importance at 100 nM.
The importance of HR for recovery to TSA exposure was
tested further in embryonic stem (ES) cells either deleted for
Brca2 exon 27 or mutated for Blm.T h eBrca2 mutation in ES
cells (brca2
lex1/lex2) is the same as described for MEF (23,24).
The Blm mutant ES cells (blm
tm3Brd/tm4Brd) express low levels
(  12%) of Blm; like Brca2, Blm is important for cell survival
and null alleles are not available for analysis (14,15). HR is
impaired by the Brca2 mutation but increased by the Blm
mutation and both mutations increase genomic instability.
Neither the brca2
lex1/lex2 nor the blm
tm3Brd/tm4Brd ES cells
exhibited a change in sensitivity to TSA compared with their
isogenic control cells (all clones of ES cells are in an isogenic
129SvEv background) (Figure 1F). Thus, neither diminished
nor enhanced HR impacts resistance to TSA in ES cells.
The impact of TSA was investigated for immortal p53
 / 
ku80
 /  MEF transfected with either a fusion of EGFP and
human Ku80 (HsKu80, mouse Ku80 will continue to be called
simply Ku80) or just EGFP (Figure 2). An EGFP–HsKu80
Figure 2. EGFP–HsKu80 function in p53
 /  ku80
 /  MEFs. (A) Percent
survival after exposure to g-radiation. Six clones of p53
 /  ku80
 /  MEFs
transfected with EGFP–HsKu80 (asterisk) are compared with three clones
transfected with EGFP (diamond) and to the parental clone of p53
 / 
ku80
 /  MEFs (crosses) and to a single clone of p53
 /  NHEJ+ MEF (circle).
Allclonesareimmortalandatgreaterthanpassage50bya3T3analysis.(Band
C) A clone of p53
 /  ku80
 /  MEFs transfected with EGFP–HsKu80 that is
resistant to g-radiation is compared to a clone of p53
 /  ku80
 /  MEF trans-
fected with EGFP for sensitivity to TSA. (B) Survival fraction after a pulse of
100 nM TSA for 0, 24 and 48 h. (C) Growth curve after exposure to a pulse of
TSA.Cells were exposed to either no TSA (closed symbols)orto 500 nM TSA
for24h(opensymbols).TimewhencellsareexposedtoTSAisshowningray.
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fected into the p53
 /  ku80
 /  MEFs. Blasticidin-resistant
clones were picked, expanded and shown to express EGFP–
HsKu80 protein by western blot analysis using either anti-
HsKu80 or anti-EGFP antibodies. Previous data show that
HsKu80 is at least partially functional in mouse cells (46).
However, the addition of EGFP may alter HsKu80 function.
Todetermineifthe EGFP–HsKu80fusionproteinisfunctional
in mouse cells, seven clones transfected with EGFP–HsKu80
were compared with three clones transfected with EGFP for
resistance to g-radiation. Resistance to g-radiation improved
for six of the seven EGFP–HsKu80 clones but not for any of
the three EGFP clones (Figure 2A). The survival fraction for
the average of these six EGFP–HsKu80 clones is similar to a
clone of immortal p53
 /  MEFs while the survival fraction for
the average of the three EGFP clones is similar to the parental
clone of p53
 /  ku80
 /  MEFs. Thus, in this cellular assay,
the EGFP–HsKu80 fusion protein is functional for repairing
damage generated by g-radiation.
AnEGFP–HsKu80clonethatwasshowntoberesistanttog-
radiation was compared with a clone of EGFP MEF for pro-
liferationafterabriefexposuretoahighconcentrationofTSA.
Thus, the impact of a pulse of TSA was determined. MEFs,
plated at low density, were exposed to 100 nM TSA for 0, 24
and 48 h; cells were then grown for 2 weeks without TSA and
colony formation observed. Formation of colonies progress-
ively declined with longer exposure to 100 nM TSA; however,
the EGFP–HsKu80 clone was more resistant than the EGFP
clone(Figure2B).There were 20-foldmore colonies after 48 h
of exposure to 100 nM TSA for the EGFP–HsKu80 clone than
for the EGFP clone. MEF, plated at high density, were
exposed to a 24 h pulse of 500 nM TSA (from day 0 to
day 1), MEF were then allowed to proliferate after removal
of TSA. Cell number declined for both clones; however, cells
recovered for the clone transfected with EGFP–HsKu80, but
not EGFP (Figure 2C). Thus, EGFP–HsKu80 was important
for recovery of p53
 /  ku80
 /  cells after exposure to a pulse
of 500 nM TSA.
Localization of the EGFP–HsKu80 and EGFP protein
was determined by ﬂuorescence microscopy in response to
g-radiation and TSA (Figure 3A–N). p53
 /  ku80
 /  MEFs
transfected with either EGFP–HsKu80 or EGFP were tested
for ﬂuorescence after exposure to either 2 Gy or 100 nM TSA.
Green ﬂuorescence was diffused throughout the cytoplasm
after exposure to either g-radiation or TSA for MEFs trans-
fected with EGFP (Figure 3H &I). Green ﬂuorescence was
also diffused for MEFs transfected EGFP–HsKu80 without
exposure to either g-radiation or TSA (Figure 3J). However,
exposure to either 2 Gy or 100 nM TSA increased nuclear
ﬂuorescence for EGFP–HsKu80 MEFs (Figure 3K–N).
Increased nuclear ﬂuorescence was observed as soon as 2 h
after exposure to TSA and persisted for at least 24 h. In addi-
tion, the levels of EGFP–HsKu80 did not change by increasing
TSA concentration from whole cell extracts (Figure 3O);
therefore, the increased nuclear ﬂuorescence observed in
EGFP–HsKu80 MEF caused by exposure to 100 nM TSA
is probably owing to translocation of EGFP–HsKu80 from
the cytoplasm to the nucleus.
TSA induces apoptosis and checkpoint responses
TSA-induced reduction in cell number may be caused by
apoptosis. The levels of apoptosis were analyzed for the
MEF exposed to 33 nM TSA during the time course displayed
in Figure 1D. MEFs were tested for apoptosis by staining with
Annexin V as they were counted during the time course
(Figure 4A). All clones exhibited positive cells showing
that reduced cell number was at least partly owing to apop-
tosis. Therefore, 33 nM TSA induces apoptosis independent of
p53 since these clones are all mutated for p53.
TSA-induced reduction in cell number may also be caused
by cell cycle checkpoints. HDAC inhibitors stimulate replic-
ative senescence by a p53-independent, p21
Cip1-dependent
response that arrests cells in G1/G0 (42,43,47). MEFs deleted
for p53 and Ku80, and transfected with either EGFP or EGFP–
HsKu80, were tested. The status of cell cycle regulators was
Figure 3. LocalizationofEGFP–HsKu80tothenucleusafterexposuretoeitherg-radiationorTSA.(A–G)DAPIstainedcells.(H–N)Observationoffluorescence.
(A and H) EGFP MEF 8 h after exposure to 200 Rads. (B and I) EGFP MEF after 24 h of exposure to 100 nM TSA. (C and J) EGFP–HsKu80 MEF (E-Ku)without
exposure. (D and K) EGFP–HsKu80 MEF 6 h after exposure to 200 Rads. (E and L) EGFP–HsKu80 MEF for 2 h of exposure to 100 nM TSA. (F and M) EGFP–
HsKu80MEFfor6h ofexposureto 100nM TSA.(Gand N) EGFP–HsKu80 MEFsfor24h ofexposureto 100nM TSA.(O) Westernblotperformedon wholecell
extractsofEGFP–HsKu80MEFafterexposureto0,20,100or500nMTSAandstainedwithanti-HsKu80antibody.ArrowpointstoEGFP–HsKu80.Theinsetwith
Coomassie stained gel demonstrates equal loading for the western blot analysis.
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INK4a and p21
Cip1 after 0–24 h of exposure
to 100 nM TSA, (Figure 4B) and the phosphorylation status of
pRb was determined after a 24 h pulse (days 0–1) of 100 nM
TSA (Figure 4C). Exposure to 100 nM TSA induced levels of
p16
INK4a, p21
Cip1 within 24 h and induced hypophosphoryla-
tion of pRb by days 5–10 for MEF with either EGFP or EGFP–
Ku80. These data show that exposure to 100 nM TSA activates
a p53-independent cellcycleresponse inp53
 / ku80
 / MEF
with and without HsKu80.
Ku80 is not essential for global deacetylation of histones
In yeast cells, Ku is important for silencing telomere-
positioned genes (48,49), implicating Ku involvement in com-
pacting chromatin. To determine if HsKu80 is important for
deacetylation of histones, the level of histone acetylation was
analyzed in p53
 /  ku80
 /  MEFs with and without HsKu80
after exposure of 100 nM TSA. The level of histone acetyla-
tion greatly increased after exposure to a 24 h pulse of 100 nM
TSA andhighlevels ofhistone acetylationpersisted foratleast
10 days for p53
 /  ku80
 /  MEFs with and without HsKu80
(Figure 4D). Thus, there is no obvious quantitative difference
in the level of genome-wide histone acetylation based on the
presence of EGFP–HsKu80, indicating that HsKu80 does not
participate in an activity that globally deacetylates histones.
Induction of phosphorylated H2AX
It is surprising that NHEJ-deleted cells are hypersensitive to a
HDAC inhibitor, an agent not known for generating DSBs.
Since both ku80
 /  and lig 4
 /  MEFs are extra sensitive to
TSA, it is possible that TSA enables the formation of DSBs;
perhaps the open chromatin caused by hyperacetylated his-
tones are more vulnerable. Therefore, we investigated the
presence of DNA DSBs by measuring phosphorylation of
the histone H2A variant, H2AX, on C-terminal serine 139,
known asg-H2AX (50).g-H2AXwas measured after exposure
to similarly toxic levels of either TSA or CPT (a topo-
isomerase 1 inhibitor known to generate DNA DSBs during
S phase) (51). g-H2AX levels were measured by ﬂow cyto-
metry analysis, nuclear ﬂuorescence and western analysis
(Figure 5). By all approaches the low doses of TSA (33 nM)
and CPT (25 nM) did not increased g-H2AX levels; however,
exposure to 85 nM CPT increased g-H2AX levels to a greater
degree than exposure to an equivalent dose of TSA (100 nM).
In addition, a very high dose of TSA did not increase g-H2AX
as judged by western analysis (Figure 5C). Thus, TSA does
not elevate g-H2AX to the same degree as equivalent doses
of CPT.
Synergy of PI-3 kinase inhibitors and TSA
TSA is a hydroxamic acid-based HDAC inhibitor that causes
growth arrest, differentiation or apoptosis of a variety of
transformed cells. Based on these observations, this class of
HDAC inhibitor is considered potentially valuable for anti-
cancer therapy (35). Data presented here demonstrate that
p53-mutant cells exposed to low levels of TSA are capable
of proliferation perhaps by adaptation. However, p53
 /  cells
are unable to proliferate in the presence of TSA if they are
disabled for the NHEJ proteins Ku80 or Lig 4. Therefore,
NHEJ proteins may be suitable therapeutic targets capable
of enhancing anti-cancer therapies that inhibit histone
deacetylation. A combination of anti-NHEJ and anti-HDAC
drugs may prove efﬁcacious for treatment of p53-mutant
tumors and would, therefore, have potential broad-based
application owing to the frequency of p53 loss during tumor
formation (52).
To test this possibility, a dose-response curve was
performed for HeLa cells exposed to three different
DNA–PKCS inhibitors: LY294002, NU7026 and vanillin.
DNA–PKCS is essential for NHEJ and belongs to the family
of PI-3 kinases that includes ATM, ATR and mTOR.
LY294002 is a non-selective competitive PI-3 kinase inhibitor
and NU7026 is an LY294002-based compound that is 5-fold
more selective for DNA–PKCS than ATM or ATR (53,54).
LY-294002 reduced cell number in synergy with TSA (16 and
33 nM), but not g-radiation (1 Gy), (Figure 6A). TSA at 33 nM
(reduces cell number by 10%) produced a dose response factor
(DRF) of 1.3–2.2 for LY-294002. On the other hand, NU7026
reduced cell number in synergy with g-radiation (1 Gy), but
Figure 4. Cellular responses of MEFs to TSA. Time 0 is the point just before
TSA is added to media. (A) Annexin V staining of MEFs analyzed for the time
coursedescribedinFigure1D.(B)Levelsofp16
INK4a,p21
Cip1observedduring
24hofexposureto100nMTSA.LevelsofhypophosphorylatedpRb(thefaster
migratingband)(C) andlevelsofhistoneacetylation(D) forMEFexposedtoa
pulseof100nMTSAfor24h(days0–1).Cellextractsweretakenatavarietyof
time points over 10 days. (B–D) Equal amounts of protein were added to each
well as verified by Coomassie stain (data not shown).
5326 Nucleic Acids Research, 2005, Vol. 33, No. 16not TSA (33 nM) (Figure 6B). g-Radiation (1 Gy) (reduces
cell number by 10%) produced a DRF of  2–4 for NU7026.
Vanillin is a natural compound that is a PI-3 kinase inhibitor
selective for DNA–PKCS over ATM and ATR. Vanillin,
similar to LY-294002, reduced cell number in synergy with
TSA (33 nM), but not g-radiation (1 Gy) (Figure 6). TSA at
33 nM(reduces cellnumberby 10%) produceda DRF of 2–4
for vanillin. Thus, PI-3 kinase inhibitors exhibit synergy with
either IR or TSA but not both, demonstrating a discrepancy
in their mode of action.
Figure5.Levelsofg-H2AXafterexposuretoTSAandCPT.Compare33nMTSAto25nMCPT(reducesthenumberofcontrolcellsby50–90%),100nMTSAto85
nMCPT(reducesthenumberofcontrolcellsbyslightly>99%)and1000nMTSAto1000nMCPT(bothdosesaremuchhigherthanusedinthedoseresponsecurve).
Fluorescence analysis by either (A) flow cytometry to quantify large numbers of cells or (B) microscopy to observe nuclear foci. (A) Analysis by flow cytometry.
Representative histograms are shown for control cells (p53
 /  NHEJ+) and NHEJ-deleted cells (p53
 /  lig 4
 /  and p53
 /  ku80
 / ). For the graph, the average
amountofg-H2AXpercellisshownrelativetotheDMSO-treatedcontrolcells.Theaverageoftwoclonesisdisplayedin3D.(B)Analysisbycellularfluorescence.
Representative examples are shown for control cells exposed to either 100 nM TSA or 85 nM CPT. (C) Analysis by western analysis for p53
 /  NHEJ+ (top) and
p53
 /  ku80
 /  (bottom) cells. The relative signal of g-H2AX to b-actin is shown.
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By our dose response assays, we measure a decrease in cell
number after exposure to TSA; either apoptosis or decreased
proliferation could be responsible. Both appear to contribute
since cells exposedto TSA exhibit increased levels of Annexin
V staining, demonstrating apoptosis and increased levels of
p16
INK4a, p21
Cip1 and hypophosphorylated pRb demonstrating
cell cycle arrest. Cells of all genotypes, including p53
 / 
MEFs, fail to proliferate after exposure to high levels of
TSA and these cellsclearlyexhibit senescent cell morphology;
thus, cell cycle arrest is not dependent on p53 as predicted
by previous results (42,43). However, p53
 /  MEFs recover
from a continuous exposure to low dose TSA or to a 24 h
pulse of high dose TSA. Therefore, p53 is important for
inhibiting cellular proliferation under these conditions.
This is not surprising since TSA increases levels of
acetylated p53 (55) and acetylation of p53 increases its
function (14,56).
The observation that NHEJ-deleted cells are hypersensitive
to TSA indicates that TSA increases DNA DSBs or at least
inﬂuences the repair of DNA DSBs. However, TSA is not
known to cause DSBs and we show that TSA fails to increase
g-H2AX levels as compared with equivalent toxic doses of
CPT.Therefore,thequantityofDSBsthatleadstocytotoxicity
after exposure to TSA is less than CPT. This observation
suggests that TSA inhibits the repair of DSBs (either spontan-
eous or generated by TSA, but at low levels). Since deletion
of NHEJ, but not alteration of HR, increases TSA sensitivity,
it is possible that TSA induces changes that increase the
importance of NHEJ such that cells are more reliant upon
this pathway. One possible explanation is that TSA-exposed
cells accumulated in G1, a cell cycle phase that depends on
NHEJ, not HR. Another possible explanation is that NHEJ is
the preferred pathway to repair a DSB with hyperacetylated
histones that would cause a more open state of chromatin
that could either inhibit HR or facilitate NHEJ. Data from
the budding yeast S.cerevisiae support this explanation
since the status of histone acetylation is important for
NHEJ but not for HR. However, these yeast data are confusing
in that NHEJ appears to be facilitated by both HAT (28,29)
and HDAC activity (30). Since histone H4 may be acetylated
on multiple lysines it is possible that acetylation of some
lysines and deacetylation of other lysines are important for
preparing the DSB for repair by NHEJ. Also, the timing
may be critical. Importantly, in yeast, both HAT (29) and
HDAC (30) activity impact NHEJ, but not HR as judged
by direct repair assays. Thus, these yeast data support the
explanation that NHEJ is preferred for repairing DSBs after
exposure to TSA. By any explanation, NHEJ, but not HR,
improves survival of immortalized cells exposed to TSA.
Recently, cells deleted for Ku70 were shown to be hyper-
sensitive to TSA (57). In addition to NHEJ, Ku70 is also
important for negatively regulating apoptosis by sequestering
Bax (58,59), a protein that promotes apoptosis. This Ku70–
Bax association is inﬂuenced by acetylation of Ku70 (60);
therefore, it is possible that Ku70-mutant cells are hyper-
sensitive to TSA owing to increased Bax-induced apoptosis,
not defective NHEJ. This possibility could also be true for
Ku80-mutant cells since deletion of Ku80 results in a marked
decrease of Ku70 (17); albeit some Ku70 is still present and its
association with Bax may not be affected. However, deletion
of Lig4 does not affect levels of Ku and would not probably
impact the Ku70–Bax association; thus, the increased sensit-
ivity to TSA is probably owing to defective NHEJ. Because
both Lig4-mutant and Ku80-mutant cells are hypersensitive
Figure 6. PI-3 kinase inhibitors in combination with TSA and g-radiation.
HeLa cells were exposed to either 33 nM TSA or 1 Gy g-radiation in combina-
tionwithvaryingdosesof(A)LY-294002,(B)vanillinand(C)NU-7026.TSA,
but not g-radiation, acts in synergy with LY-294002 and vanillin to reduce cell
numberwhileg-radiation,butnotTSA,actsinsynergywithNU-7026toreduce
cell number. Survival fraction after exposure to 1 Gy is 0.92 ± 0.064
(top dashed line), to 33 nM TSA is 0.81 ± 0.061 (bottom dashed line), to
1Gy+ 33nMTSAis0.083 ± 0.039(middledashedline,almostsuperimposed
with the bottom dashed line).
5328 Nucleic Acids Research, 2005, Vol. 33, No. 16to TSA, it is likely that at least part of the sensitivity of
Ku70-mutant cells is due to defective NHEJ perhaps in com-
bination with defective regulation of Bax. This possibility is
supported by our observation that ku80
 /  MEFs exhibit the
same sensitivity as lig 4
 /  MEFs at 33 nM TSA but greater
sensitivity at 100 nM TSA; suggesting problems in addition to
defective NHEJ are associated with deletion of Ku80 that is
revealed with a higher dose of TSA.
Since cells exposed to TSA depend on NHEJ for survival,
the combination of a HDAC inhibitor and an anti-NHEJ
molecule could be useful for treating cancer. TSA and other
HDAC inhibitors are being considered as potential anti-cancer
therapeutics because they induce cell cycle arrest and
apoptosis. Inhibitors to the PI-3 kinase family that includes
DNA–PKcs are also being considered as potential anti-cancer
therapeutics because they should sensitize cells to DSBs
caused by g-radiation if they inhibit ATM, ATR or DNA–
PKcs. We show that the PI-3 kinase inhibitors, LY294002
and vanillin, reduced HeLa cell number with synergy in com-
bination with TSA but not g-radiation. The opposite was found
to be true for another PI-3 kinase inhibitor NU7026. These
observations show the complexity of these PI-3 kinase
inhibitors. Since LY294002 and NU7026 are in the same
family, one would predict they would give similar results
(perhaps to varying degrees). In addition, if LY294002 and
NU7026 truly inhibited DNA–PKcs,one would expect synergy
with both radiation and TSA. This discrepancy could be due
to the varying speciﬁcities these agents have for inhibiting
different PI-3 kinases; however, the same expectation could
be made for inhibiting other PI-3 kinases like ATM and ATR.
NU7026 is more speciﬁc for DNA–PKcs than LY294002 sug-
gesting that inhibition of DNA–PKcs produces synergy with
irradiation but not TSA. However, again there is confusion
since vanillin, another PI-3 kinase inhibitor that is speciﬁc
to DNA–PKcs, exhibits synergy with TSA but not with
g-radiation. It is possible that vanillin and NU7026 both
inhibit DNA–PKcs but at different active sites that are speciﬁc
for responding to either TSA or irradiation, respectively.
Alternatively, the dose of TSA may differentially impact
proteins (compare Figure 1D to E) and cellular outcomes
(Figure 1A). Thus, the complexity of these interactions may
be inﬂuenced by TSA dose in relationship to the complexity
of a living cell in ways that in vitro assays cannot predict
and point to the necessity of testing inhibitors in living sys-
tems. Even though these data are confusing, the genetic data is
straightforward and show that the NHEJ proteins, Ku80 and
Lig4 are important for survival of cells exposed to TSA and
support the notion that PI-3 kinase inhibitors act in synergy
with TSA by inhibiting NHEJ.
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